Menu

LeMaitre Vascular, Inc. LMAT

Full chart Compare
Set alert

Price alert · LMAT

All alert types
83.49 USD -4.43 (-5.04%)

At closeNov 6, 2026, 7:04 AM EST

85.00 +1.51 +1.81%

Pre-market · Nov 6, 7:04 AM ET

80.73 Day range 85.97
78.22 52-week range 118.01
YTD
+2.95%
1 year
-3.22%
Market cap
1.91B
Revenue (ttm)
262.43M
Profit margin
25.02%
EPS (ttm)
2.75
Shares out
22.87M
P/E ratio
30.36
Forward P/E
27.66
Dividend
1.00 (1.24%)
Ex-dividend date
Aug 19, 2026
YTD return
+2.95%
1-year return
-3.22%
Volume
533.76K
Avg volume
300.44K
Open
81.79
Previous close
87.92
Day's range
80.73 – 85.97
52-week range
78.22 – 118.01
Beta
0.49
Analysts
Buy
Price target
107.00 (+28.2%)
Earnings date
Feb 24, 2027

5D -1.33 (-1.57%)

8085FriMonTueWedThu83.49

Key statistics

Enterprise value
1.66B
PEG ratio
2.13
Price / sales
7.66
Price / book
4.78
Dividend yield
1.24%
Payout ratio
31.58%
Revenue growth
9.60%
Free cash flow
49.26M
Total cash
376.24M
Total debt
190.25M
Return on equity
16.77%
Short % of float
9.76%
50-day average
81.20
200-day average
94.40

Financials — quick view

All financials
LMAT Revenue — quarterly 70.38M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LMAT Net income — quarterly 17.05M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LMAT EPS — quarterly 0.75
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LMAT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 24, 2027Dec 30, 20260.78———
Nov 4, 2026Sep 30, 20260.6860.65-0.04-5.25%
Aug 4, 2026Jun 30, 20260.8070.74-0.07-8.30%
May 5, 2026Mar 31, 20260.660.68+0.02+3.03%
Feb 25, 2026Dec 31, 20250.670.68+0.01+1.49%
Nov 6, 2025Sep 30, 20250.5640.62+0.06+9.93%

Upgrades / downgrades

LMAT analyst upgrades and downgrades
DateFirmActionFromTo
Aug 5, 2026Wells FargomainEqual-WeightEqual-Weight
Jun 3, 2026Barrington ResearchmainOutperformOutperform
May 6, 2026Barrington ResearchmainOutperformOutperform
May 6, 2026CitizensmainMarket OutperformMarket Outperform
May 6, 2026Wells FargomainEqual-WeightEqual-Weight
Feb 26, 2026Barrington ResearchmainOutperformOutperform

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
lemaitre.com

News

Your note

Sign in to keep a note on LMAT — it syncs with the Stock Master app.

Insider holders

LMAT insider holders
InsiderRelationLatest transactionDateShares held
JASINSKI LAWRENCE JDirectorSaleMay 6, 20264,714
KAMKE TRENT GOfficerSaleMar 10, 20266,677
LEBLANC DORIAN PAUL CPAChief Financial OfficerConversion of Exercise of derivative securityMar 9, 20262,302
LEMAITRE GEORGE WChief Executive OfficerStock Award(Grant)Jun 3, 20260
O'CONNOR JOHN JAMES EDWARDDirectorStock Award(Grant)Feb 25, 202662,827
PELLEGRINO JOSEPH P JRDirectorConversion of Exercise of derivative securityApr 21, 202615,021

Institution ownership

LMAT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.31%3,272,973287.76MJun 29, 2026
First Trust Advisors LP4.78%1,093,50296.14MJun 29, 2026
Congress Asset Management Co4.20%961,51484.54MSep 29, 2026
Vanguard Capital Management LLC4.17%953,43783.83MJun 29, 2026
Copeland Capital Management, LLC4.04%924,08181.25MSep 29, 2026
State Street Corporation3.94%901,41679.25MJun 29, 2026

Fund ownership

LMAT fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.53%1,265,638111.27MSep 29, 2026
First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers4.64%1,061,70393.34MSep 29, 2026
Conestoga Funds-Conestoga Small Cap Fund3.80%869,01676.40MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.02%690,80660.74MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.46%563,06249.50MSep 29, 2026
Professionally Managed Portfolios-Congress Small Cap Growth Fund2.06%470,00041.32MSep 29, 2026